Asthma biologics omalizumab and dupilumab both ease symptoms but move IgE in opposite directions
A retrospective real-world cohort of 72 adults with moderate-to-severe asthma found both omalizumab and dupilumab improved asthma control and lung ...
A retrospective real-world cohort of 72 adults with moderate-to-severe asthma found both omalizumab and dupilumab improved asthma control and lung ...
An integrative reanalysis of 778 baseline mucosal transcriptomes from public ulcerative colitis cohorts identified three gene-expression endotypes that stratify healing ...
A narrative review synthesizes real-world evidence supporting single-inhaler triple therapy and the emergence of dupilumab, mepolizumab and the investigational anti-IL-33 ...
A cross-sectional study of 76 adults with Crohn’s disease at a Baghdad hospital found that higher ustekinumab trough concentrations were ...
A case report shows tocilizumab-induced hypofibrinogenemia recurred in a rheumatoid arthritis patient even after the drug dose was substantially reduced.
A 52-week Japanese observational study found that tildrakizumab sustained meaningful disease control in real-world psoriasis patients, with 60 percent achieving ...
An unsupervised machine-learning analysis of the Italian LIRE registry has identified four clinically distinct phenotypes among systemic lupus erythematosus patients ...
A Japanese case report describes dissecting cellulitis of the scalp that resisted two biologic drugs, with surgery revealing hair shafts ...
A retrospective study of 61 Crohn's disease patients in China found that ustekinumab delivers stronger inflammatory control and endoscopic healing ...
A new review maps where the off-label anti-CD20 antibody rituximab fits in the treatment of systemic lupus erythematosus, from refractory ...
© 2026 Scienmag - Science Magazine
© 2026 Scienmag - Science Magazine